ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

New Drugs Improve Outlook For Bone Marrow Cancer

March 31, 2006

Budget Cuts Delay New Cooperative Drug Discovery Groups For Lung, Colon Cancer At Least One Year

February 21, 1986

Medicare coverage and quality of care top ASCO’s list of policy priorities for 2004.

February 27, 2004

In Brief: It’s Finally Official: DRCCA Name Changed To DCPC, Old DCCP Is Div. Of Cancer Etiology

December 9, 1983

Vanderbilt Lung Cancer Trial For Never Smokers Online

September 25, 2009

Quality Of Care Varies Widely For Prostate Cancer, Study Says

August 29, 2008